Symbols / HSCS Stock $2.00 -0.50% HeartSciences Inc.

Healthcare • Medical Devices • United States • NCM
HSCS (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Andrew Simpson
Exch · Country NCM · United States
Market Cap 6.37M
Enterprise Value 6.84M
Income -8.49M
Sales 8.67K
FCF (ttm) -4.21M
Book/sh 0.83
Cash/sh 1.07
Employees 15
Insider 10d —
IPO Jun 16, 2022
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -0.71
PEG —
P/S 734.73
P/B 2.40
P/C —
EV/EBITDA -0.88
EV/Sales 789.07
Quick Ratio 0.80
Current Ratio 1.19
Debt/Eq 145.81
LT Debt/Eq —
EPS (ttm) -4.49
EPS next Y -2.83
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-03-16
Earnings (prior) 2026-03-16
ROA -73.51%
ROE -3.82%
ROIC —
Gross Margin 57.92%
Oper. Margin -899.40%
Profit Margin 0.00%
Shs Outstand 3.18M
Shs Float 3.07M
Insider Own 2.34%
Instit Own 6.21%
Short Float 0.93%
Short Ratio 2.28
Short Interest 28.78K
52W High 6.47
vs 52W High -69.09%
52W Low 1.89
vs 52W Low 5.82%
Beta 2.45
Impl. Vol. —
Rel Volume 2.06
Avg Volume 17.12K
Volume 35.27K
Target (mean) $10.00
Tgt Median $10.00
Tgt Low $8.00
Tgt High $12.00
# Analysts 2
Recom None
Prev Close $2.01
Price $2.00
Change -0.50%
About

HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$10.00
Mean price target
2. Current target
$2.00
Latest analyst target
3. DCF / Fair value
$-23.81
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.00
Low
$8.00
High
$12.00
Mean
$10.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-24 main Ascendiant Capital Buy → Buy $8
2025-12-22 main Ascendiant Capital Buy → Buy $9
2025-10-01 main Ascendiant Capital Buy → Buy $9
2025-03-18 main Ascendiant Capital Buy → Buy $14
2024-12-18 reit Maxim Group Buy → Buy $12
2024-09-23 reit Ascendiant Capital Buy → Buy $15
2023-01-30 init Ascendiant Capital — → Buy $3
2022-12-19 main Maxim Group — → Buy $3
2022-11-09 init Maxim Group — → Buy $8
2022-08-08 init Benchmark — → Speculative Buy $8
News
RSS: Latest HSCS news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-11-28 SIMPSON ANDREW Chief Executive Officer — 70,000 $0.00 $0
2025-07-29 HILZ MARK T Chief Operating Officer — 4,416 $3.54 $15,621
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-04-30 2024-04-30 2023-04-30 2022-04-30
Total Revenue
0.00
-76.61%
0.02
+261.17%
0.01
-64.17%
0.01
Operating Revenue
0.00
-76.61%
0.02
+261.17%
0.01
-64.17%
0.01
Cost Of Revenue
0.00
-69.08%
0.01
+117.49%
0.00
-64.56%
0.01
Reconciled Cost Of Revenue
0.00
-69.08%
0.01
+117.49%
0.00
-64.56%
0.01
Gross Profit
0.00
-80.27%
0.01
+431.82%
0.00
-63.69%
0.01
Operating Expense
8.36
+32.24%
6.32
+3.32%
6.12
+29.67%
4.72
Research And Development
4.39
+52.37%
2.88
+16.97%
2.46
-18.01%
3.00
Selling General And Administration
3.97
+15.38%
3.44
-5.88%
3.65
+113.17%
1.71
Total Expenses
8.36
+32.14%
6.32
+3.37%
6.12
+29.52%
4.72
Operating Income
-8.35
-32.46%
-6.31
-3.15%
-6.11
-29.80%
-4.71
Total Operating Income As Reported
-8.35
-32.46%
-6.31
-3.15%
-6.11
-29.80%
-4.71
EBITDA
-8.14
-32.18%
-6.16
-3.02%
-5.98
-34.89%
-4.43
Normalized EBITDA
-8.14
-32.18%
-6.16
-3.02%
-5.98
-27.68%
-4.68
Reconciled Depreciation
0.13
+34.50%
0.10
-29.77%
0.14
+409.87%
0.03
EBIT
-8.26
-32.21%
-6.25
-2.29%
-6.11
-37.12%
-4.46
Total Unusual Items
—
—
0.00
-100.00%
0.25
Total Unusual Items Excluding Goodwill
—
—
0.00
-100.00%
0.25
Special Income Charges
—
—
0.00
-100.00%
0.25
Other Special Charges
—
—
—
-0.25
Net Income
-8.77
-32.70%
-6.61
-3.95%
-6.35
-31.61%
-4.83
Pretax Income
-8.77
-32.70%
-6.61
-3.95%
-6.35
-31.61%
-4.83
Net Non Operating Interest Income Expense
-0.50
-41.34%
-0.35
-45.61%
-0.24
+34.56%
-0.37
Interest Expense Non Operating
0.50
+41.34%
0.35
+45.61%
0.24
-34.56%
0.37
Net Interest Income
-0.50
-41.34%
-0.35
-45.61%
-0.24
+34.56%
-0.37
Interest Expense
0.50
+41.34%
0.35
+45.61%
0.24
-34.56%
0.37
Other Income Expense
0.09
+60.67%
0.05
+2856.82%
0.00
-99.27%
0.25
Other Non Operating Income Expenses
0.09
+60.67%
0.05
+2856.82%
0.00
-27.76%
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-8.77
-32.70%
-6.61
-3.95%
-6.35
-31.61%
-4.83
Net Income From Continuing Operation Net Minority Interest
-8.77
-32.70%
-6.61
-3.95%
-6.35
-31.61%
-4.83
Net Income From Continuing And Discontinued Operation
-8.77
-32.70%
-6.61
-3.95%
-6.35
-31.61%
-4.83
Net Income Continuous Operations
-8.77
-32.70%
-6.61
-3.95%
-6.35
-31.61%
-4.83
Normalized Income
-8.77
-32.70%
-6.61
-3.95%
-6.35
-25.12%
-5.08
Net Income Common Stockholders
-8.77
-32.70%
-6.61
-3.95%
-6.35
-31.61%
-4.83
Diluted EPS
-9.34
+50.16%
-18.74
+76.58%
-80.00
-34.41%
-59.52
Basic EPS
-9.34
+50.16%
-18.74
+76.58%
-80.00
-34.41%
-59.52
Basic Average Shares
0.94
+166.16%
0.35
+343.39%
0.08
-1.99%
0.08
Diluted Average Shares
0.94
+166.16%
0.35
+343.39%
0.08
-1.99%
0.08
Diluted NI Availto Com Stockholders
-8.77
-32.70%
-6.61
-3.95%
-6.35
-31.61%
-4.83
Gain On Sale Of PPE
—
—
—
0.00
Line Item Trend 2023-04-30
Total Assets
3.29
Current Assets
2.70
Cash Cash Equivalents And Short Term Investments
1.66
Cash And Cash Equivalents
1.66
Receivables
0.00
Accounts Receivable
0.00
Inventory
0.68
Raw Materials
0.67
Work In Process
0.02
Finished Goods
0.03
Prepaid Assets
0.14
Current Deferred Assets
0.18
Other Current Assets
0.04
Total Non Current Assets
0.59
Net PPE
0.59
Gross PPE
1.06
Accumulated Depreciation
-0.47
Properties
0.00
Machinery Furniture Equipment
0.10
Other Properties
0.93
Leases
0.03
Goodwill And Other Intangible Assets
0.00
Total Liabilities Net Minority Interest
3.06
Current Liabilities
1.83
Payables And Accrued Expenses
1.25
Payables
0.63
Accounts Payable
0.63
Current Accrued Expenses
0.62
Current Debt And Capital Lease Obligation
0.53
Current Debt
0.50
Other Current Borrowings
0.50
Current Capital Lease Obligation
0.03
Other Current Liabilities
0.05
Total Non Current Liabilities Net Minority Interest
1.22
Long Term Debt And Capital Lease Obligation
1.04
Long Term Debt
0.50
Long Term Capital Lease Obligation
0.54
Stockholders Equity
0.23
Common Stock Equity
0.23
Capital Stock
0.00
Common Stock
0.00
Preferred Stock
0.00
Share Issued
0.10
Ordinary Shares Number
0.10
Treasury Shares Number
0.00
Additional Paid In Capital
60.99
Retained Earnings
-60.76
Total Equity Gross Minority Interest
0.23
Total Capitalization
0.73
Working Capital
0.86
Invested Capital
1.23
Total Debt
1.57
Net Debt
—
Capital Lease Obligations
0.57
Net Tangible Assets
0.23
Tangible Book Value
0.23
Interest Payable
0.24
Inventories Adjustments Allowances
-0.04
Non Current Accrued Expenses
0.19
Preferred Stock Equity
0.00
Line Item Trend 2025-04-30 2024-04-30 2023-04-30 2022-04-30
Operating Cash Flow
-7.41
-22.12%
-6.07
-5.14%
-5.77
-58.43%
-3.64
Cash Flow From Continuing Operating Activities
-7.41
-22.12%
-6.07
-5.14%
-5.77
-58.43%
-3.64
Net Income From Continuing Operations
-8.77
-32.70%
-6.61
-3.95%
-6.35
-31.61%
-4.83
Depreciation Amortization Depletion
0.13
+34.50%
0.10
-29.77%
0.14
+409.87%
0.03
Depreciation
0.13
+34.50%
0.10
-29.77%
0.14
+409.87%
0.03
Amortization Cash Flow
—
—
—
0.00
Depreciation And Amortization
0.13
+34.50%
0.10
-29.77%
0.14
+409.87%
0.03
Amortization Of Intangibles
—
—
—
0.00
Other Non Cash Items
0.46
-15.34%
0.54
+310.04%
0.13
-31.41%
0.19
Stock Based Compensation
0.25
-38.30%
0.41
+63.11%
0.25
+263.04%
0.07
Operating Gains Losses
—
—
—
-0.23
Gain Loss On Investment Securities
—
—
—
0.02
Gain Loss On Sale Of PPE
—
—
—
0.00
Change In Working Capital
0.52
+202.68%
-0.50
-870.66%
0.07
-94.18%
1.12
Change In Receivables
-0.00
0.00
-100.00%
0.00
+200.00%
-0.00
Changes In Account Receivables
-0.00
0.00
-100.00%
0.00
+200.00%
-0.00
Change In Inventory
-0.02
-144.70%
0.05
+2225.23%
-0.00
-102.90%
0.08
Change In Prepaid Assets
0.36
+50.89%
0.24
-38.58%
0.39
+431.92%
0.07
Change In Payables And Accrued Expense
-0.11
+53.39%
-0.24
+11.18%
-0.27
-122.24%
1.22
Change In Accrued Expense
0.02
+128.61%
-0.06
+81.08%
-0.31
-135.84%
0.87
Change In Payable
-0.13
+29.29%
-0.18
-584.31%
0.04
-89.46%
0.36
Change In Account Payable
-0.13
+29.29%
-0.18
-584.31%
0.04
-89.46%
0.36
Change In Other Working Capital
0.40
+177.76%
-0.52
-955.62%
0.06
+124.53%
-0.25
Change In Other Current Assets
—
—
—
—
Change In Other Current Liabilities
-0.10
-250.51%
-0.03
+72.79%
-0.11
—
Investing Cash Flow
-0.03
+75.90%
-0.13
-584.24%
-0.02
-847.62%
-0.00
Cash Flow From Continuing Investing Activities
-0.03
+75.90%
-0.13
-584.24%
-0.02
-847.62%
-0.00
Net PPE Purchase And Sale
-0.00
+95.10%
-0.06
-252.06%
-0.02
-847.62%
-0.00
Purchase Of PPE
-0.00
+95.10%
-0.06
-252.06%
-0.02
-847.62%
-0.00
Sale Of PPE
—
—
—
—
Capital Expenditure
-0.03
+75.90%
-0.13
-584.24%
-0.02
-847.62%
-0.00
Net Intangibles Purchase And Sale
-0.03
+55.55%
-0.06
0.00
—
Purchase Of Intangibles
-0.03
+55.55%
-0.06
0.00
—
Financing Cash Flow
2.73
-73.57%
10.34
+58.29%
6.53
+70.12%
3.84
Cash Flow From Continuing Financing Activities
2.73
-73.57%
10.34
+58.29%
6.53
+70.12%
3.84
Net Issuance Payments Of Debt
1.59
+3621.04%
0.04
+110.70%
-0.40
-109.42%
4.23
Issuance Of Debt
1.85
+453.57%
0.33
0.00
-100.00%
4.73
Repayment Of Debt
-0.26
+9.39%
-0.29
+26.78%
-0.40
+20.35%
-0.50
Long Term Debt Issuance
1.85
+453.57%
0.33
0.00
-100.00%
4.73
Long Term Debt Payments
-0.26
+9.39%
-0.29
+26.78%
-0.40
+20.35%
-0.50
Net Long Term Debt Issuance
1.59
+3621.04%
0.04
+110.70%
-0.40
-109.42%
4.23
Short Term Debt Issuance
—
—
—
0.00
Net Short Term Debt Issuance
—
—
—
0.00
Net Common Stock Issuance
1.15
-88.86%
10.30
+83.14%
5.62
0.00
Proceeds From Stock Option Exercised
—
0.00
-100.00%
1.31
0.00
Net Other Financing Charges
—
—
—
-0.39
Changes In Cash
-4.71
-213.56%
4.15
+458.76%
0.74
+281.05%
0.19
Beginning Cash Position
5.81
+249.76%
1.66
+80.83%
0.92
+26.92%
0.72
End Cash Position
1.10
-81.09%
5.81
+249.76%
1.66
+80.83%
0.92
Free Cash Flow
-7.44
-20.14%
-6.20
-6.97%
-5.79
-58.85%
-3.65
Common Stock Issuance
1.15
-88.86%
10.30
+83.14%
5.62
0.00
Issuance Of Capital Stock
1.15
-88.86%
10.30
+83.14%
5.62
0.00
Net Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Issuance
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category